Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Stroke prevention].

M Arnold1, K Nedeltchev, Ph Lyrer

  • 1Neurologische Universitätskliniken Bern. marcel.arnold@insel.ch

Therapeutische Umschau. Revue Therapeutique
|October 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An open letter: In solidarity with all children suffering in wars; to all who hold or share a concern for the wellbeing of children.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Response: Why solidarity with all children suffering in wars is not antisemitic.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Bunch length measurement setup for femtocoulomb bunch charges at the superconducting Darmstadt electron linear accelerator S-DALINAC.

The Review of scientific instruments·2025
Same author

Multichannel laser diode to polymer waveguide array coupling with a double-aspheric lens.

Applied optics·2023
Same author

Intra-Arterial Thrombolysis is Associated with Delayed Reperfusion of Remaining Vessel Occlusions following Incomplete Thrombectomy.

AJNR. American journal of neuroradiology·2023
Same author

Endovascular therapy outcome in isolated posterior cerebral artery occlusion strokes: A multicenter analysis of the Swiss Stroke Registry.

European stroke journal·2023
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Lifestyle changes and medications like antihypertensives and antithrombotics can reduce stroke risk. Antiplatelet agents and warfarin are key for preventing recurrent strokes and managing specific conditions.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Lifestyle modifications are crucial for reducing stroke risk.
  • Several drug classes, including antihypertensives, antidiabetics, statins, and antithrombotics, are effective in managing patients with stroke risk factors.

Purpose of the Study:

  • To review the pharmacological strategies for stroke risk reduction and secondary stroke prevention.
  • To outline the primary and alternative medication choices for different stroke types and patient profiles.

Main Methods:

  • Review of established pharmacological treatments for stroke prevention.
  • Analysis of antiplatelet agents and anticoagulants in secondary stroke prevention.

Main Results:

Related Experiment Videos

  • Antiplatelet agents (aspirin, aspirin/dipyridamole, clopidogrel) are first-line for non-cardioembolic ischemic stroke prevention.
  • Warfarin is effective for cardioembolic stroke, cerebral venous thrombosis, and antiphospholipid antibody syndrome, with other potential indications.

    • Conclusions:

    • Pharmacological interventions, tailored to stroke type and patient factors, are essential for secondary stroke prevention.
    • Antiplatelet therapy and anticoagulation with warfarin represent cornerstone treatments in managing cerebrovascular disease.